The major role of EHV-1 in equine abortion is widely reported in the literature but the 21 contribution of EHV-2, EHV-3, EHV-4 or EHV-5 remains less well documented. The 22 objective of this study is to evaluate the contribution of these five different EHVs to equine 23 abortion in a variety of biological tissues using a consensus polymerase chain reaction (PCR). 24
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The test was validated for specificity and sensitivity in horses before screening specimens 25 from 407 foetuses, stillbirths and premature foals collected over a 2½-year interval. Positive 26 results obtained with this assay were compared to other EHV type-specific PCR or by 27 sequencing. EHV-1 was identified as the major cause of abortion in French mares (59/407 28 cases). However, there was evidence to suggest some variation in the potential of EHV-1 29 strains to induce abortion. Indeed, DNA samples from EHV-2 (in three cases) and one case) inferred a role of these viruses in abortion. The presence of viral DNA from EHV-3 31 or EHV-4 strains was not detected in the specimens studied. The data obtained suggest that 32 -6 -The consensus herpesvirus PCR method as described by VanDevanter et al. (1996) was used 113 in this study. The assay employed a nested format in which primary and secondary PCRs 114 were performed with degenerate PCR primers targeted to highly conserved amino acid motifs 115 directed to the DNA polymerase gene. Primary PCR mixtures contained two upstream 116 primers (DFA and ILK) and one downstream primer (KG1) in a multiplex format. A 117 secondary PCR was performed on 2.5 µL of the primary PCR mixture in a 25 µL volume with 118 upstream primer TGV and downstream primer IYG under the same thermal conditions as 119 those used for the primary reaction. 120
The size of the amplified fragment was between 215 and 315 bp. DNA from a Kentucky 121 reference strain (Ky A) obtained from ATCC was used as a control for EHV-1. Other DNA 122 controls (EHV-2, EHV-3 and EHV-4) came from our laboratory collection. The typing of all 123 the different strains was based on sequencing. The specificity of the consensus herpesvirus 124 PCR for EHV was assessed by testing DNA extracts of various pathogens implicated in 125 diseases of the horse: Streptococcus equi subsp. zooepidemicus, Streptoccoccus equi subsp. 126
equi, Listeria monocytogenes, Listeria innocua, Leptospira interrogans serovar australis, 127
Leptospira biflexa, Coxiella burnetii, Chlamydophila abortus, Rhodococcus equi, Taylorella 128 equigenitalis, equine arteritis virus and Neospora caninum. 129
Analytical sensitivity of the assay was tested using a suspension of EHV-1 grown in cell 130 culture (RK13). The viral suspension was diluted 10-fold (10 -1 to 10 -8
) and titrated on RK13 131 cells. Simultaneously, DNA was extracted from these dilutions and used for detection of virus 132 in consensus and specific PCR. The results were obtained in triplicate and the minimum 133 quantity necessary to allow detection of the virus was determined (expressed as the TCID 50 ). 134
Specific PCRs for EHV-1 or EHV-4 detection were adapted from a previously described 135 method (Kirisawa et al., 1993) . Primers R1 and FC3 were used for amplification of an 188 bp 136 A c c e p t e d M a n u s c r i p t -7 -fragment internal to the glycoprotein B gene of EHV-1 and primers R4 and FC3 for 137 amplification of a 677 bp fragment of glycoprotein B gene of EHV-4. 138 EHV-2 was detected by amplification of a sequence upstream from the ORF coding for a 139 product homologous to human Interleukin-10, within the EcoR1 N fragment of EHV-2, as 140 previously described (Borchers et al., 1997) . This PCR test was intended to amplify fragments 141 between 521 and 721 bp. Primary PCR mixtures contained an upstream primer ALM1 and 142 one downstream primer ALM2. Secondary PCR was performed on 2.5 µL of the primary 143 PCR mixture in 25 µL with upstream primer ALM3 and downstream primer ALM4 under the 144 same conditions used for the primary reaction. 145
For specific detection of EHV-3, we developed a one-step PCR test using primers HSP3F and 146 HSP3R to amplify a fragment of 100 bp in the DNA polymerase gene. 147
All PCR tests included a negative control where DNA was replaced with distilled water. The 148 amplified products were analyzed by electrophoresis (2% agarose gel) and their size estimated 149 by comparison with molecular weight markers (SmartLadder SF) run in parallel. 150
Visualization was performed under UV transillumination after soaking the gels in ethidium 151 bromide (50 ng /µL). 152
Only positive samples, as determined by consensus herpesvirus PCR and negative by specific 153 EHV-1 PCR, were sequenced after extraction of the PCR product from agarose gel through 154 the use of a QIAquick extraction kit 
Virus isolation 159
Virus isolation was performed on foetal and neonatal lung tissue. Tissue samples were 160 homogenized in minimum essential medium (MEM) supplemented with 100 U penicillin, 100 161 A c c e p t e d M a n u s c r i p t -8 -µg/mL streptomycin and 0.25 µg/mL amphotericin B to produce approximately 10% tissue 162 suspension that was centrifuged at 3000 g for 30 minutes at 4°C. The supernatant fluid was 163 filtered through a 0.45 µm membrane and 100 µL was inoculated onto subconfluent 164 monolayers of rabbit kidney cells (RK13) in a 25 cm 2 flask. To prevent any possible effects of 165 cytotoxicity, the inoculums were replaced, after adsorption during 1 h 15 min at 37°C, by 7 166 mLl of culture medium (MEM supplemented with 10% of foetal calf serum, 1% of L-167 glutamine, 100 U penicillin, 100 µg/mL streptomycin and 0.25 µg/mL of amphotericin B). 168
The cultures were incubated at 37°C for up to one week and the cytopathic effect (CPE) was 169 checked daily. Monolayers with no CPE at the end of seven days were seeded once more on 170 RK13 cells and the CPE was checked daily over a three-week interval. 171
Histopathology 172
Tissues samples were taken from lung and placenta and fixed in 10% formalin solution. The 173 samples were embedded in paraffin and 4 µm thick sections were cut and stained with 174 haematoxylin and eosin. 175
Sequencing 176
Sequencing was performed on the amplified fragment from the secondary PCR product of the 177 consensus herpesvirus PCR. 178
Results 179

Validation of the consensus herpesvirus PCR for each equine virus 180
Concerning specificity of the consensus herpesvirus PCR, no product was amplified from 181 DNA of various micro-organisms implicated in diseases of the horse (see 2.2 above). DNA 182 fragments of the expected size were amplified from DNA extracts of EHV-1, EHV-2, EHV-3 183 and EHV-4. Specificity of each fragment was confirmed by sequencing. 184
The limits of detection for the assays were 10 -5 and 10 -6 TCID50/50µL for specific EHV-1 185 and consensus herpesvirus PCR, respectively and with an EHV-1 (Ky A) viral suspension 186 A c c e p t e d M a n u s c r i p t -9 -with a known titre of 10 -4.8 TCID 50 /50µL. Consensus herpesvirus PCR shows a sensitivity that 187 is one log higher that the specific EHV-1 PCR. 188
Detection of EHV 189
Firstly, for each animal, the lung and placenta were analysed by the consensus herpesvirus 190 Using specific EHV-1 PCR, we also analysed 49 samples for which lung and placenta were 209 both available. Twenty-two cases (45%) were positive for both organs, 3 cases (6%) were 210 positive only for lung, 8 cases (16%) were positive only for placenta and 16 cases (33%) were 211 Nevertheless, the evidence suggests the existence of two subgroups: in the first subgroup (25 227 cases), PCR signals were observed in DNA from lung or placenta by the two PCRs 228 (consensus and specific EHV-1 PCR), in the second subgroup (15 cases), only consensus 229 PCR showed a positive signal and confirmed the presence of herpesvirus. Thus, although 230 herpesviral DNA was present in lung and placenta in these samples, EHV-1 was not 231 confirmed by specific PCR or culture. 232
The application of the consensus herpesvirus PCR to tissues from a large population of equine 233 abortion and neonatal deaths allowed us to detect three positive cases of EHV-2 confirmed by 234 specific EHV-2 PCR. However, the viruses could not be isolated and histopathological lesions 235
were not observed. The sequencing of a positive consensus herpesvirus PCR product also 236 A c c e p t e d M a n u s c r i p t -11 -allowed us to detect a sequence that had 100% homology with a sequence of EHV-5 but once 237 again, the virus could not be isolated and histopathological lesions were absent. As such, there 238 is no evidence to implicate EHV-5 in abortion. Furthermore, the samples studied were not 239 positive for EHV-3 or EHV-4. 240
Discussion 241
This is the first French study to present molecular biology data relative to abortion in mares 242 due to herpesvirus.. The incidence 15% (67/407) of herpesviruses is not in agreement with 243 that reported in the literature. Two retrospective studies showed lower rates of EHV in 244 abortion in the UK (7% by Smith et al., 2003) and in the USA (4% by Giles et al., 1993) as 245 detected by virus isolation and a direct fluorescent antibody test coupled with cell culture, 246
respectively. The use of a nested consensus PCR followed by specific PCR, or sequencing, 247 might have increased the sensitivity of the present method. The limit of detection (10 -6 248 TCID 50/50µL) is comparable with other methods (Elia et al., 2006; Diallo et al., 2007) . 249
Moreover, the extraction protocol was optimal (high quality of samples) and the presence of 250 inhibitors was not observed. The findings suggest that, at least during the 2½ years of the 251 study, the prevalence of EHV-1 in abortion is greater than that mentioned in previous reports. 252
Analysis of the placenta confirmed recent data reported by Gerst et al. (2003) and Smith et al. 253 (2004) and stresses the importance of including this tissue in the diagnosis of abortion. 254
Concerning EHV-1, 15 viruses were detected by consensus PCR. In fact, an absence of signal 255 with specific PCR could be related to lower efficiency of the one-step test, or to heterogeneity 256 of the glycoprotein B gene which could alter the annealing of the specific primers. Moreover, 257 the nucleotide sequencing of DNA polymerase gene (samples that were shown to be positive 258 with a consensus herpesvirus PCR and negative with the specific EHV-1 PCR) revealed no 259 difference with the EHV-1 strains Ab4 and V592. However, recent studies demonstrated 260 differences between the two strains Ab4 and V592 (Allen and Breathnach, 2006; Kydd et al., 261 A c c e p t e d M a n u s c r i p t -12 -2006; Nugent et al., 2006; Slater et al., 2006) and particularly in a specific area of the 262 polymerase gene (ORF30 coding for the catalytic subunit of the DNA polymerase). The Ab4 263 strain was identified as an endotheliotropic, abortigenic and paralytic virus that causes a high 264 level viremia, whereas the V592 strain was identified as a less abortigenic virus that produces 265 no neurological damage (Allen and Breathnach, 2006) . 266
The presence of EHV-4 was not detected but this strain is not normally related with abortion; 267 some reports suggest a putative role in abortion only in a minority of isolates studied (Ostlund 268 et al., 1993; Smith et al., 2003) . Indeed, we detected EHV-4 only once in a foetus in 1999. 269
The absence of the EHV-3 gene in the population studied suggests that this virus is minimally 270 involved in cases of abortion even if its tropism is in the genital tract. Only a few studies 271 looked for the presence of EHV-3 and none reported its presence in naturally occurring 272 abortion over the last 27 years (Feilen et al., 1979) . 273 EHV-2 was detected in three specimens which represents 0.74% of the samples studied and 274 confirms the recent data of Galosi et al., (2005) . The role of this virus in abortion is still not 275
clear. 276
The only EHV-5 genome detected in our study was confirmed by sequencing. Studies 277 involving isolated cultures are currently ongoing but the data are not yet available. 278 Nevertheless, the 100% identity of the sequence with that of the reference strain (AF141886) 279 confirms the presence of EHV-5 in our specimens. 280
In the present 2½-year study, we demonstrated that the consensus herpesvirus DNA 281 polymerase PCR is appropriate for the detection of all known equine herpesviruses (type 1 to 282 5) present in placenta or lung tissue (from aborted or neonatal foal deaths). We have validated 283 this assay to show the involvement of herpesvirus in abortion. Moreover, since 1998, this test 284 has been successfully used in our laboratory on different DNA extracts from spinal, broncho-285 alveolar or trans-tracheal fluid. The use of this consensus herpesvirus PCR appears to be a 286 A c c e p t e d M a n u s c r i p t -13 -good rapid diagnostic tool for use in veterinary laboratories. This approach is sensitive and 287 broadly applicable to the detection and identification of previously characterized 288 herpesviruses present in equine tissues and can also provide valuable initial sequence 289 information for previously unreported equine herpesviruses. This test has already allowed us 290 to detect one case of asinine herpesvirus on an aborted foetus issued from a she-ass (AHV4 291 with the GenBank accession number AY054992). 292 A c c e p t e d M a n u s c r i p t -14 -Blanchard, T.L., Kenney, R.M., Timoney, P.J., 1992. Venereal disease. Vet. Clin. North Am. 317
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